Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters
Tài liệu tham khảo
Ren, 2020, Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study, Chin Med J, 133, 1015, 10.1097/CM9.0000000000000722
Bösmüller, 2021, The pulmonary pathology of COVID-19, Virchows Archiv, 478, 137, 10.1007/s00428-021-03053-1
Ackermann, 2020, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19, N Engl J Med, 383, 120, 10.1056/NEJMoa2015432
Menter, 2020, Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction, Histopathology, 77, 198, 10.1111/his.14134
Bösmüller, 2020, The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation, Virchows Arch, 477, 349, 10.1007/s00428-020-02881-x
Lax, 2020, Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series, Ann Intern Med, 173, 350, 10.7326/M20-2566
Carsana, 2020, Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study, Lancet Infect Dis, 20, 1135, 10.1016/S1473-3099(20)30434-5
Winkler, 2020, SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function, Nat Immunol, 21, 1327, 10.1038/s41590-020-0778-2
Winkler, 2020, SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function, bioRxiv
Sun, 2020, A mouse model of SARS-CoV-2 infection and pathogenesis, Cell Host Microbe, 28, 124, 10.1016/j.chom.2020.05.020
Abdel-Moneim, 2020, Evidence for SARS-CoV-2 infection of animal hosts, Pathogens, 9, 529, 10.3390/pathogens9070529
Sia, 2020, Pathogenesis and transmission of SARS-CoV-2 in golden hamsters, Nature, 583, 834, 10.1038/s41586-020-2342-5
Chan, 2020, Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility, Clin Infect Dis, 71, 2428, 10.1093/cid/ciaa644
Imai, 2020, Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development, Proc Natl Acad Sci U S A, 117, 16587, 10.1073/pnas.2009799117
Osterrieder, 2020, Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters, Viruses, 12, 779, 10.3390/v12070779
Tostanoski, 2020, Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters, Nat Med, 26, 1694, 10.1038/s41591-020-1070-6
Kreye, 2020, A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model, Cell, 183, 1058, 10.1016/j.cell.2020.09.049
Munster, 2020, Respiratory disease in rhesus macaques inoculated with SARS-CoV-2, Nature, 585, 268, 10.1038/s41586-020-2324-7
Baum, 2020, REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters, Science, 370, 1110, 10.1126/science.abe2402
Kim, 2020, Infection and rapid transmission of SARS-CoV-2 in ferrets, Cell Host Microbe, 27, 704, 10.1016/j.chom.2020.03.023
Muñoz-Fontela, 2020, Animal models for COVID-19, Nature, 586, 509, 10.1038/s41586-020-2787-6
Zeiss, 2021, Animal models of COVID-19, I: comparative virology and disease pathogenesis, ILAR J, 10.1093/ilar/ilab007
Veenhuis, 2021, Animal models of COVID-19, II: comparative immunology, ILAR J, 10.1093/ilar/ilab010
Rogers, 2020, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Science, 369, 956, 10.1126/science.abc7520
Bankhead, 2017, QuPath: open source software for digital pathology image analysis, Sci Rep, 7, 16878, 10.1038/s41598-017-17204-5
Morriss, 2020, Automated quantification of immunohistochemical staining of large animal brain tissue using QuPath software, Neuroscience, 429, 235, 10.1016/j.neuroscience.2020.01.006
2011
Dhakal, 2021, Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model, bioRxiv
Gniazdowski, 2021, Repeat COVID-19 molecular testing: correlation of SARS-CoV-2 culture with molecular assays and cycle thresholds, Clin Infect Dis, 73, 860, 10.1093/cid/ciaa1616
Meyers, 1956, A histological and cytological study of the adrenal gland of the golden hamster (Cricetus auratus) in relation to age, Anat Rec, 124, 1, 10.1002/ar.1091240102
Gruber, 2020, Standardization of reporting criteria for lung pathology in SARS-CoV-2-infected hamsters: what matters?, Am J Respir Cell Mol Biol, 63, 856, 10.1165/rcmb.2020-0280LE
Polak, 2020, A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression, Mod Pathol, 33, 2128, 10.1038/s41379-020-0603-3
Baseler, 2015, Syrian hamsters (Mesocricetus auratus) oronasally inoculated with a Nipah virus isolate from Bangladesh or Malaysia develop similar respiratory tract lesions, Vet Pathol, 52, 38, 10.1177/0300985814556189
Prescott, 2013, The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster, Immunology, 140, 168, 10.1111/imm.12116
Liu, 2020, Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine, 55, 102763, 10.1016/j.ebiom.2020.102763
Wang, 2020, Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia, J Infect Dis, 221, 1762, 10.1093/infdis/jiaa150
Liu, 2020, Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage, J Transl Med, 18, 206, 10.1186/s12967-020-02374-0
Tan, 2020, Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduct Target Ther, 5, 33, 10.1038/s41392-020-0148-4
Diao, 2020, Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19), Front Immunol, 11, 827, 10.3389/fimmu.2020.00827